Eledon Pharmaceuticals Inc Ordinary Shares ELDN 深 滬
等待開盤 12-19 09:30:00 美东时间
1.57
0.000
0.00%
華盛通- 最 高1.64
- 今 開1.59
- 成交量 56.38万股
- 最 低 1.55
- 昨 收 1.57
- 總市值 1.18亿
- 52周最高 4.98
- 市盈率 靜 --
- 換手率 0.75%
- 52周最低 1.35
- 委 比 -45.39%
- 總股本 7503.43万
- 歷史最高 154.98
- 量 比 0.63
- 振 幅 5.73%
- 歷史最低 1.07
- 每 手 1
- 風險率 0.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
Eledon Pharmaceuticals announced that CEO David-Alexandre C. Gros, M.D., will participate in a fireside chat at the 37th Annual Piper Sandler Healthcare Conference on December 4, 2025. The webcast can be registered in advance via the provided link, with a replay available post-event on the company’s website. Eledon is a clinical-stage biotech company developing immune-modulating therapies, with its lead product, tegoprubart, targeting CD40L for c...
12-01 12:00
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
Guggenheim Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $8
Guggenheim analyst Vamil Divan maintains Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and lowers the price target from $9 to $8.
11-18 22:10
Eledon Pharmaceuticals GAAP EPS of -$0.21
Eledon Pharmaceuticals press release (ELDN): Q3 GAAP EPS of -$0.21. Cash, cash equivalents and short-term investments totaled $93.4 million as of September 30, 2025 compared to $140.2 million as of De...
11-15 06:43
Eledon Pharma Q3 EPS $(0.21) Beats $(0.24) Estimate
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.24) by 11.39 percent. This is a 25 percent increase over losses of $(0.28) per share from the
11-15 06:05
Eledon Pharmaceuticals Launches ~$50M Offering Of 15.2M Common Shares At $1.65/Share; 15.2M Warrants At $1.649/Warrant
Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering price of $1.65 per share and (ii)
11-12 20:59
Eledon Pharmaceuticals drops 10% on stock offering
Eledon Pharmaceuticals (ELDN) commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares. The...
11-12 20:05
IES Holdings To Buy Gulf Island For $192 Million
IES Holdings Inc. will acquire Gulf Island Fabrication Inc. for $192 million in cash, at a 52% premium to the stock's last close.
11-08 02:59
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Eledon shares drop as tegoprubart misses the main goal in Phase 2 kidney transplant trial, though safety signals and kidney function data remain encouraging.
11-08 02:36
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
Eledon Pharmaceuticals stock fell hard on Friday after the company released cli...
11-07 21:50
